137 related articles for article (PubMed ID: 30623362)
1. Colorectal Cancer Subtypes - The Current Portrait.
Jordan P
Adv Exp Med Biol; 2018; 1110():1-6. PubMed ID: 30623362
[TBL] [Abstract][Full Text] [Related]
2. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.
Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R
World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
4. Simple classifiers for molecular subtypes of colorectal cancer.
Kim WG; Kim JY; Park DY
Arab J Gastroenterol; 2017 Dec; 18(4):191-200. PubMed ID: 29241727
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathological classification of colorectal cancer-an update.
Dunne PD; Arends MJ
Virchows Arch; 2024 Feb; 484(2):273-285. PubMed ID: 38319359
[TBL] [Abstract][Full Text] [Related]
6. Age at onset should be a major criterion for subclassification of colorectal cancer.
Perea J; Rueda D; Canal A; Rodríguez Y; Álvaro E; Osorio I; Alegre C; Rivera B; Martínez J; Benítez J; Urioste M
J Mol Diagn; 2014 Jan; 16(1):116-26. PubMed ID: 24184227
[TBL] [Abstract][Full Text] [Related]
7. Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.
Sadanandam A; Wang X; de Sousa E Melo F; Gray JW; Vermeulen L; Hanahan D; Medema JP
Cell Cycle; 2014; 13(3):353-7. PubMed ID: 24406433
[TBL] [Abstract][Full Text] [Related]
8. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer.
Inoue M; Takahashi S; Soeda H; Shimodaira H; Watanabe M; Miura K; Sasaki I; Kato S; Ishioka C
Int J Clin Oncol; 2015 Dec; 20(6):1147-55. PubMed ID: 25990448
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers and pathway analysis of colorectal carcinoma in the Middle East.
Beg S; Siraj AK; Prabhakaran S; Bu R; Al-Rasheed M; Sultana M; Qadri Z; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
Cancer; 2015 Nov; 121(21):3799-808. PubMed ID: 26218848
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
[TBL] [Abstract][Full Text] [Related]
13. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.
Cantini L; Isella C; Petti C; Picco G; Chiola S; Ficarra E; Caselle M; Medico E
Nat Commun; 2015 Nov; 6():8878. PubMed ID: 27305450
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.
Fessler E; Medema JP
Trends Cancer; 2016 Sep; 2(9):505-518. PubMed ID: 28741479
[TBL] [Abstract][Full Text] [Related]
16. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
Rüschoff J; Aust D; Hartmann A
Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
[TBL] [Abstract][Full Text] [Related]
17. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
18. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
19. Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer.
Liu D
FEBS J; 2016 Aug; 283(16):3115-33. PubMed ID: 27376509
[TBL] [Abstract][Full Text] [Related]
20. New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
Cohen R; Svrcek M; Dreyer C; Cervera P; Duval A; Pocard M; Fléjou JF; de Gramont A; André T
Curr Oncol Rep; 2016 Mar; 18(3):18. PubMed ID: 26861657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
